BE847861A - NEW AMINO-BENZAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS - Google Patents
NEW AMINO-BENZAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTSInfo
- Publication number
- BE847861A BE847861A BE171987A BE171987A BE847861A BE 847861 A BE847861 A BE 847861A BE 171987 A BE171987 A BE 171987A BE 171987 A BE171987 A BE 171987A BE 847861 A BE847861 A BE 847861A
- Authority
- BE
- Belgium
- Prior art keywords
- benzamides
- preparation
- medicinal products
- new amino
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/50—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving creatine phosphokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752548968 DE2548968A1 (en) | 1975-11-03 | 1975-11-03 | Orally-active amino-benzamides - useful as anxiolytics, anticonvulsants, antiemetics and antiulcer cpds. |
Publications (1)
Publication Number | Publication Date |
---|---|
BE847861A true BE847861A (en) | 1977-04-29 |
Family
ID=5960614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE171987A BE847861A (en) | 1975-11-03 | 1976-10-29 | NEW AMINO-BENZAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU508953B2 (en) |
BE (1) | BE847861A (en) |
DE (1) | DE2548968A1 (en) |
ZA (1) | ZA766385B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT389994B (en) * | 1978-03-23 | 1990-02-26 | Astra Laekemedel Ab | Use of novel 2,6-dialkoxybenzamides for producing antipsychotic medicines |
FI74707C (en) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA ALKYLENOEVERBRYGGADE PIPERIDYLESTRAR ELLER -AMIDER AV BICYKLISKA KARBOXYLSYROR. |
GB8302483D0 (en) * | 1983-01-29 | 1983-03-02 | Beecham Group Plc | Compounds |
US4593034A (en) | 1984-04-06 | 1986-06-03 | A. H. Robins Company, Inc. | 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides |
DE3688296T2 (en) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | MEDICINES FOR TREATING EMERGENCY. |
US4717563A (en) * | 1986-03-05 | 1988-01-05 | A. H. Robins Company, Inc. | 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs |
US4722834A (en) * | 1986-03-05 | 1988-02-02 | A. H. Robins Company, Incorporated | Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs |
EP0272052B1 (en) * | 1986-12-16 | 1992-07-08 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Anxiolytic-N-(1-Azabicyclo[2.2.2]Oct-3-yl) Benzamides and Thobenzamides |
-
1975
- 1975-11-03 DE DE19752548968 patent/DE2548968A1/en active Pending
-
1976
- 1976-10-25 ZA ZA00766385A patent/ZA766385B/en unknown
- 1976-10-29 BE BE171987A patent/BE847861A/en unknown
- 1976-11-03 AU AU19281/76A patent/AU508953B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2548968A1 (en) | 1977-05-12 |
AU508953B2 (en) | 1980-04-17 |
AU1928176A (en) | 1978-05-11 |
ZA766385B (en) | 1978-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2329266A1 (en) | NEW AMINO-BENZAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
BE849542A (en) | NEW QUINAZOLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
FR2343731A1 (en) | NEW AMINOALCOYLHETEROCYCLES, METHODS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
FR2337718A1 (en) | NEW ETHERIFIED HYDROXY-BENZODIHETEROCYCLES, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE859067A (en) | NEW PEPTIDIC AMINO-ETHERS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2305975A2 (en) | NEW AMIDINOURAES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE865165A (en) | NEW 1-AMINO-INDANES AND THEIR USE AS MEDICINAL PRODUCTS | |
BE863160A (en) | NEW AMINOALCOXYPHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
FR2303560A1 (en) | NEW POLYPEPTIDES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE847861A (en) | NEW AMINO-BENZAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
MC1223A1 (en) | NEW 2-IMINO-IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE874683A (en) | NEW BICYCLO-OCTANIC DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
BE869640A (en) | NEW 2-PYRIDYL- AND 2-PYRIMIDYL-AMINO-BENZOIC ACIDS, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
BE847373A (en) | NEW DERIVATIVES OF CYCLOHEXYLPHENYL, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
BE862275A (en) | NEW SULFAMOYLBENZOIC ACIDS, THEIR PREPARATRION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE790604A (en) | NEW AMINOALCANOLS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE864290A (en) | NEW ARYL-HEXAFURANOSIDES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE856157A (en) | NEW N-BENZYLAMINOACIDS SULFRED, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
FR2314707A1 (en) | NEW HYDROXYALCYL TETRAIODO-TEREPHTHALATES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
MC1222A1 (en) | NEW 2,4-DIAMINO-5-BENZYLPYRIMIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE853328A (en) | NEW OXOTHIA COMPOUNDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
FR2341584A1 (en) | NEW THIENOTHIAZINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
BE864318A (en) | NEW TRIAZOLO-THIENO-DIAZEPINE-1-ONES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
BE862038A (en) | 1-AMINO-ALKYL LOWER-3,4-DIPHENYL-1H-PYRAZOLES AND THEIR USE AS MEDICINAL PRODUCTS | |
FR2341557A1 (en) | NEW DERIVATIVES OF 2-PHENYL-2-HYDROXYETHYLAMINE, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS |